Aim of this poster is to describe post radiofrequency ablation (RFA) appearances of renal tumours and also to point out signs of renal tumour recurrence after the procedure.
The incidence of renal cell carcinoma (RCC) has been gradually increasing.
there have been improvements in treatment options also .
Most renal cancers are now detected at early-stage being suitable for nephron-sparing ablative procedures,
such as radiofrequency ablation (RFA),
micro-wave ablation (MWA). Compared to minimally invasive surgery for RCC,
percutaneous ablation is less invasive with fewer complications and faster convalescence .
Findings and procedure details
After RFA of renal tumours,
follow up CT scan at our institution is performed at 1,4,7 and 11 months and then yearly for 5 years.
Appearances post RFA can be variable. Disease surveillance must be undertaken using a dedicated CT renal mass protocol with unenhanced and contrast-enhanced CT scan as the bare minimum ,
because abnormal enhancement is key indicator of residual or recurrent local disease. After successful effective ablation,
tumor is seen as area of hyper-density (> 40 HU) ...
Image-guided percutaneous thermal ablation is a promising treatment option for renal tumors. Better tumour detection has led to increase in patients undergoing radiological follow up for image guided percutaneous renal tumour ablation.
Radiologists need to be aware of post radiofrequency ablation (RFA) appearances in order to detect recurrent/residual renal tumour.
Dr Muhammad Fahad Shahzad Shaukat International Training Fellow Radiology Heartlands Hospital Birmingham,
UK Dr Sadia Sultana Radiology Registrar Heartlands Hospital Birmingham,
UK Dr Madava Djearaman Consultant Radiologist Clinical Lead Thermal Ablation HeartlandsHospital Birmingham,
UK Dr Shahid Hussain ConsultantRadiologist CT Clinical Lead Radiology Directorate Simulation Lead Birmingham RadiologyScheme Heartlands Hospital Birmingham,
1.American Cancer Society Website.
Accessed December 18,
2018 2.Hui GC,
Comparison of percutaneous and surgical approaches to renal tumor ablation: meta-analysis of effectiveness and complication rates.
J Vasc Interv Radiol 2008; 19:1311–132 3.Kowalczyk KJ,
costs and trends in treatment...